Lunai Bioworks (LNAI) Proxy filing summary

Executive summary

• Special Meeting of Stockholders postponed from May 4, 2026, to May 8, 2026, to allow more time for voting and to ensure quorum requirements are met.

• Meeting will be held virtually with no physical location; access requires a 16-digit control number.

• Postponement addresses timing issues with broker discretionary voting under NYSE Rule 452 due to proxy material distribution delays.

• Record date for voting remains April 10, 2026, with 36,271,119 shares eligible.

• Forward-looking statements highlight risks related to quorum, voting outcomes, broker authority, Nasdaq listing compliance, and technical disruptions.

Voting matters and shareholder proposals

• Proposal 1: Approve a reverse stock split at a ratio between 1-for-3 and 1-for-30, ratio to be set by the Board.

• Proposal 2: Approve adjournment of the meeting if more time is needed to solicit proxies for Proposal 1.

• Other business may be transacted as appropriate at the meeting.

Board of directors and corporate governance

• Directors and executive officers may be deemed participants in proxy solicitation; their interests are detailed in the proxy statement and recent SEC filings.

• CEO David Weinstein signed the notice and supplement as Chief Executive Officer and Director.